DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy
Venlo, the Netherlands, and Deerfield Beach, Florida, Nov. 30, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DNA Labs International announced today that DLI has recently solved two decades-old “cold cases” using QIAGEN solutions.
- Venlo, the Netherlands, and Deerfield Beach, Florida, Nov. 30, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DNA Labs International announced today that DLI has recently solved two decades-old “cold cases” using QIAGEN solutions.
- By utilizing QIAGEN’s ForenSeq Kintelligence Kit for forensic investigative genetic genealogy (FIGG) to sequence targeted DNA regions, a profile suitable for genealogy research was produced.
- Rachel Oefelein, Chief Scientific Officer at DNA Labs International, stated: “Our mission at DNA Labs International is to help law enforcement provide justice and answers to the families and victims of crime.
- “We are honored to collaborate with partners like DNA Labs International, who expertly leverage our workflow to work with authorities to deliver justice for victims of crime and their families.”
DLI has used forensic genetic genealogy to help solve many other cases.